KEY INFORMATION DOCUMENT 1/3PURPOSE This document provides you with key information about this investment product. It is not marketing material. The information is required by law to help you understand the nature, risks, costs, potential gains and losses of this product and to help you compare it with other products. PRODUCT BNP Paribas Easy FTSE EPRA Nareit Global Developed Green CTB UCITS ETF, a sub-fund of BNP PARIBAS Easy ICAV, share class: UCITS ETF EUR Capitalisation (IE0007YP0PL1) Manufacturer: BNP PARIBAS ASSET MANAGEMENT Europe (« BNPP AM ») Website: https://www.bnpparibas-am.com call +33.1.58.97.13.09 for more information. The Central Bank of Ireland (“CBI”) is responsible for supervising the Product. BNPP AM is authorised in France and regulated by the Autorité des marchés financiers (“AMF”). Date of production of the KID: 03/03/2025 WHAT IS THIS PRODUCT? Type This Product is an undertaking for collective investment in transferable securities (UCITS) qualifying as an exchange-traded fund (ETF). It is a sub-fund of BNP PARIBAS Easy ICAV, an open-ended investment vehicule with variable capital organised governed by the laws of Ireland as well as by UCITS Directive 2009/65/CE. Term This Product has no maturity date. BNPP AM is not entitled to terminate the Product unilaterally. The board of directors of the ICAV has the authority to decide to terminate the Product under specific circumstances as descibed in the prospectus. Objectives Investment Objective: The investment objective of the Fund is to replicate the performance of the FTSE EPRA Nareit Developed Green EU CTB (NTR) Index (Bloomberg: FENGRECN Index) (the “Index”) while aiming to minimise the tracking error between the Fund’s Net Asset Value per Share and the Index. By replicating the performance of the Index, the Fund aims to provide investors with exposure to companies worldwide while taking into account environmental, social and governance (“ESG”) criteria, specifically the minimum standards of Commission Delegated Regulation (EU) 2020/1818 as regards minimum standards for EU Climate Transition Benchmarks and EU Paris-aligned Benchmarks (the “Delegated Acts”) relating to Climate Transition Benchmarks (“CTB”) which include, but are not limited to, targeting the reduction of greenhouse gas emission by at least 30% relative to the Parent Index (as defined below) and an additional decarbonisation target of at least 7% each year as defined in the Delegated Acts. Investment Policy: In order to achieve its investment objective, the Fund pursues a passively managed (index tracking) strategy. The Fund will generally seek to replicate the Index by holding all of the Index equity securities in a similar proportion to their weighting in the Index (Full Replication as defined in the Prospectus). However, the Fund may employ Optimised Replication (as defined in the Prospectus) and select Index equity securities in order to build a representative portfolio that provides a return that is comparable to that of the Index. The Index is composed of global listed real estate companies and REITS of the following regions: North America, Developed Europe, Japan and Developed Asia-Pacific ex Japan, chosen according ESG criteria : green building certification, energy usage, Transition Pathway Initiative Management Quality score, carbon emission intensity, while aiming to comply with the Climate Transition Benchmark (CTB) targets of reducing carbon intensity by at least 30% relative to the initial investment universe and achieving an additional decarbonisation target of at least 7% each year, as defined in the framework of the European Benchmark Regulation. The Index selects securities based on ESG criteria such as environmental opportunity, pollution and waste, carbon emission, human capital, corporate governance and based on their efforts to reduce their exposure to coal and unconventional fossil fuels. As a result, companies involved in sectors with a potentially high negative ESG impact, those subject to significant violations of the UN Global Compact principles and those involved in severe ESG-related controversies are excluded from investment by the Fund. The extra-financial strategy of the Index, carried out at each step of the investment process, may comprise methodological limitations such as the Extra-financial Criteria and Sustainable Investments Risk or the Index rebalancing. Further information on the Index, its composition, calculation and rules for monitoring and periodic rebalancing, as well as information on the general methodology common to all FTSE Russell indices, can be found at www.ftserussell.com. The Fund’s base currency is EUR. Distribution Policy: It is not the current intention of the Directors to declare dividends in respect of Classes identified as “Capitalisation”. Recommendation: This Fund is suitable for medium to long term investment, though the Fund may also be suitable for shorter term exposure to the Index. Please refer to the supplement of the Fund (the “Supplement”) for additional details about the objective and investment policy. Intended retail investors This Product is designed for investors who have neither financial expertise nor any specific knowledge to understand the Product but nevertheless may bear a total capital loss. It is suited for clients who seek growth of capital. Potential investors should have an investment horizon of at least 5 years. Practical InformationCustodian: BNP PARIBAS, Dublin BranchThis key information document is prepared for the aforementioned share class and describes a sub-fund of BNP PARIBAS Easy ICAV. Further information aboutthe Product is contained in the prospectus and periodical reports which are issued at the level of the ICAV. The ICAV is structured as an umbrella fund withsegregated liability between sub-funds. The Instrument of Incorporation provides that the ICAV may offer separate Classes of Shares, each representing interestsin a sub-fund with each sub-fund comprising of a distinct portfolio of investments.Further information about the Product including the latest prospectus, key information document, net asset values, latest published prices of share(s), periodicalreport, investment description, may be obtained free of cost, in English, from BNPP AM or online at https://www.bnpparibas-am.com. KEY INFORMATION DOCUMENT 2/3WHAT ARE THE RISKS AND WHAT COULD I GET IN RETURN? Risk Indicator The risk indicator assumes you keep the Product for 5 years. The risk indicator assumes you keep the Product for 5 years. You may not be able to sell your Product easily or you may have You may not be able to sell your Product easily or you may have to to sell at a price that significantly impacts on how much you get sell at a price that significantly impacts on how much you get back. back.Lower risk Higher risk The summary risk indicator is a guide to the level of risk of this Product compared to other Products. It shows how likely it is that the Product will lose money because of movements in the markets or because we are not able to pay you. We have classified this Product as 4 out of 7, which is a medium risk class. The risk category is justified by the investment mainly in equities, the value of which can fluctuate considerably. These fluctuations are often amplified in the short term. Other risk materially relevant to the Product not included in the summary risk indicator:Operational risk: in the event of an operational breakdown within the management company, one of its representatives or the depositary, investors could facevarious disruptions (late payment, delivery etc.). For additional details regarding the risks, please refer to the prospectus. This Product does not include any protection from future market performance so you could lose some or all of your investment. Performance Scenarios The figures shown include all the costs of the Product itself, but may not include all the costs that you pay to your advisor or distributor. The figures do not take into account your personal tax situation, which may also affect how much you get back. What you will get from this product depends on future market performance. Market developments in the future are uncertain and cannot be accurately predicted. The unfavourable,moderate and favourable scenarios presented represent examples using the best and worst performance, as well as the average performance of the Product and/or appropriate benchmark over the last 10 years. The markets could develop very differently in the future. The stress scenario shows what you might get back in extreme market circumstances. Recommended holding period: 5 yearsIf you exit after 1 year If you exit after 5 years Example Investment: EUR 10,000 Scenarios MinimumThere is no minimum guaranteed return. You could lose some or all of your investment.What you might get back after costs 6,138.07 EUR3,053.12 EUR StressAverage return each year -38.62% -21.12%What you might get back after costs 7,357.53 EUR8,730.89 EUR UnfavourableAverage return each year -26.42% -2.68%What you might get back after costs10,321.09 EUR 10,365.54 EUR ModerateAverage return each year 3.21% 0.72%What you might get back after costs13,825.79 EUR 12,702.47 EUR FavourableAverage return each year38.26% 4.90% The below scenarios occurred for an investment using a suitable proxy. The favorable scenario occurred for an investment between 2016 and 2021. The moderate scenario occurred for an investment between 2015 and 2020. The unfavorable scenario occurred for an investment between 2021 and 2025. WHAT HAPPENS IF BNPP AM IS UNABLE TO PAY OUT? The ICAV is incorporated as a separate entity distinct from BNPP AM. In the event BNPP AM would default, the assets of the Product/ICAV, held by a depositary, would not be affected by this default. In case of default of the depositary, the risk of financial loss of the Product/ICAV is mitigated by the legal segregation of the assets of the depositary from those ofthe Product/ICAV. WHAT ARE THE COSTS? The person advising on or selling you this Product may charge you other costs. If so, this person will provide you with information about these costs and how they affect your investment. If this Product is used as an underlying of an insurance policy or a capitalization policy, the costs presented do not include any costs related to such policies. Costs over time The tables show the amounts that are taken from your investment to cover different types of costs. These amounts depend on how much you invest, how long you hold the Product. The amounts shown here are illustrations based on an example investment amount and different possible investment periods. We have assumed:in the first year, you would get back the amount that you invested (0% annual return). For the other holding periods we have assumed the Product performs asshown in the moderate scenario.EUR 10,000 is invested.If you exit after 1 year If you exit after 5 years Total Cost45 EUR 235.33 EUR Annual Cost Impact (*) 0.45%0.45% each year KEY INFORMATION DOCUMENT 3/3 (*) This illustrates how costs reduce your return each year over the holding period. For example it shows that if you exit at the recommended holding period your average return per year is projected to be 1.17% before costs and 0.72% after costs. Composition of costs One-off entry or exit costsIf you exit after 1 year Entry costs (*)We do not charge an entry cost. 0 EUR Exit costs (*) We do not charge an exit cost.0 EUR Recurring costs levied annually Management costs and other administrative and 0.41% of the value of your investment per year. The amount is based on an estimate of the 41 EUR operating costs charges that will be taken out of your money.0.04% of the value of your investment per year. This is an estimate of the costs incurred when Transaction costs we buy and sell the underlying investments for the Product. The actual amount may vary. This 4 EURfigure is therefore indicative and may be revised upwards or downwards. Incidental costs taken under specific conditions Performance fees There is no performance fee for this Product. 0 EUR (*) We do not charge an entry or exit cost on the secondary market. Retail investors who are neither authorised participants nor authorised investors will indeed generally be able to buy or sell shares only on the secondary market where shares of the Product are traded with the assistance of an intermediary (e.g. a broker). In this case, those investors may incur fees and costs which are payable to the intermediary but not charged by the Product itself or its Manufacturer. You can find this out from your financial adviser. It shall be noted that the prospectus describes the maximum costs applicable on the primary market usually for authorised participants and authorised investors and/or in exceptional circumstances. In case of conversion, no fee will be charged. HOW LONG SHOULD I HOLD IT AND CAN I TAKE MONEY OUT EARLY? The RHP has been defined and based on the risk and reward profile of the Product. Investors are able to redeem on a daily basis (on bank business days) as described in the prospectus. Any redemption occurring before the end of the RHP may adversely impact the performance profile of the Product. HOW CAN I COMPLAIN? For any claim, you are invited to contact your usual relationship manager that advised you on the Product. You can also contact BNPP AM, as described on its website www.bnpparibas-am.com (Footnote ‘Complaints management policy’), by writing to BNPP AM - Client Service - SA 90007 - 92729 Nanterre CEDEX. OTHER RELEVANT INFORMATION In order to access the Product’s past performances and performance scenarios, please follow the instructions below: (1) Click on https://www.bnpparibas-am.com (2) On the welcome page, choose "Ireland' country" and choose the language and your investor profile; acceptweb site terms and conditions (3) Go to tab 'FUNDS' and 'Fund explorer' (4) Search for the Product using the ISIN code or the Product’s name and click on the Product (5) Click on the 'Performance' tab. The chart on the website shows the Product’s performance as the percentage loss or gain over the last year compared to its benchmark. It can help you assess how the Product has been managed in the past and compare it to its benchmark.